Americans Harvey J. Alter and Charles M. Rice, and British-born scientist Michael Houghton were awarded the Nobel Prize for Medicine or Physiology on Monday for the discovery of the hepatitis C virus, a major source of liver disease that affects millions worldwide.
Several drugs approved for the treatment of hepatitis C viral infection have been identified as potential candidates against COVID-19 caused by the SARS-CoV-2 coronavirus, according to a study based on extensive calculations using supercomputer simulations.
Globally, it is estimated that 71 million individuals are chronically infected with hepatitis C virus, that attacks the liver and leads to inflammation.
Sharing of equipment used for injecting drug use was found as the substantial cause of disease burden and a contributor to blood-borne virus transmission.
However, Hepatitis E was the most common Hepatitis infection commonly diagnosed in India
The study by Indian Society for Clinical Research suggests that around 12 million people in the country are affected by HCV
According to the estimate, more than 70 million people in the world are suffering from Hepatitis C infection
28th July is observed as World Hepatitis Day to raise awareness about this silent killer, Hepatitis.
Hepatitis E virus (HEV) causes live disease that affects nearly 20 million people around the world every year and consumes the lives of more than 56,000.
Not making proper use of injections such as reusing it, incorrect disposal and poor sterilisation of syringes are increasingly contributing to Hepatitis-C Virus infection in India, claim doctors. This deadly disease, that does
Peshawar: Mullah Mohammad Yaqoob, the eldest son of late Mullah Omar, has revealed that his father died of Hepatitis C.In an audio tape released on Sunday night, authenticated by Afghan Taliban sources, Mullah Mohammad Yaqoob
New Delhi: These days when most of the couples living in metros suffer infertility. This piece of information might come handy for people who are longing to have a baby.According to the World Health Organization,
Drug major Cipla today announced the launch of generic drug Sofosbuvir for treating chronic Hepatitis C under the brand name 'Hepcvir', in India."Following the non-exclusive licensing agreement signed with Gilead Sciences in September last year
Top News
Latest News
